tolazamide has been researched along with Adenoma, Islet Cell in 1 studies
Tolazamide: A sulphonylurea hypoglycemic agent with actions and uses similar to those of CHLORPROPAMIDE.
tolazamide : An N-sulfonylurea that is 1-tosylurea in which a hydrogen attached to the nitrogen at position 3 is replaced by an azepan-1-yl group. A hypoglycemic agent, it is used for the treatment of type 2 diabetes mellitus.
Adenoma, Islet Cell: A benign tumor of the pancreatic ISLET CELLS. Usually it involves the INSULIN-producing PANCREATIC BETA CELLS, as in INSULINOMA, resulting in HYPERINSULINISM.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ahlquist, DA | 1 |
| Nelson, RL | 1 |
| Callaway, CW | 1 |
1 other study available for tolazamide and Adenoma, Islet Cell
| Article | Year |
|---|---|
Pseudoinsulinoma syndrome from inadvertent tolazamide ingestion.
Topics: Adenoma, Islet Cell; Aged; Female; Humans; Medication Errors; Pharmacists; Tolazamide; Tolmetin | 1980 |